Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/69876
Campo DC Valoridioma
dc.contributor.authorTabraue, Carlosen_US
dc.contributor.authorLara, Pedro C.en_US
dc.contributor.authorDe Mirecki-Garrido, Mercedesen_US
dc.contributor.authorDe La Rosa, Juan Vladimiren_US
dc.contributor.authorLópez-Blanco, Félixen_US
dc.contributor.authorFernández-Pérez, Leandroen_US
dc.contributor.authorBoscá, Lisardoen_US
dc.contributor.authorCastrillo, Antonioen_US
dc.date.accessioned2020-02-05T12:50:57Z-
dc.date.available2020-02-05T12:50:57Z-
dc.date.issued2019en_US
dc.identifier.issn0360-3016en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/69876-
dc.description.abstractPurpose: To evaluate the role of liver X receptor (LXR) nuclear receptors on irradiation-induced cell death and polarization of macrophages and the potential implications in the context of radiation therapy treatment of cancer. Methods and Materials: Primary and immortalized murine bone marrow–derived macrophages (BMDMs) from wild type or LXR double knock-out mice were exposed to gamma irradiation. Subsequently, analysis of LXR signaling on cell proliferation and cytotoxicity induced by ionizing radiation was determined by time-lapse photomicroscopy. Genotoxic cell damage was evaluated by Western blot of γ-H2AX and p53. Pyroptosis was analyzed through cell viability assay, lactate dehydrogenase release assay, and Western blot of caspase-1 active protein. Expression of inflammatory markers was measured by real-time quantitative polymerase chain reaction. Results: Genetic and pharmacologic inactivation of LXR induced radiosensitivity of macrophages. LXR deficiency decreased cell proliferation and enhanced cytotoxicity induced by ionizing radiation in both immortalized and primary BMDMs. Protein levels of γ-H2AX and p53, both involved in response to cell damage, were exacerbated in LXR-deficient macrophages exposed to irradiation. Cell membrane damage was augmented and cell viability was decreased in LXR-deficient macrophages compared with LXR wild type macrophages in response to irradiation. In addition, LXR deficiency enhanced both caspase-1 activation and lactate dehydrogenase release in BMDM exposed inflammasome activators. LXR inactivation or deficiency markedly increased the expression of proinflammatory markers IL-1β, IL-6, and inducible nitric oxide synthase in irradiated macrophages. Conclusions: The present work identifies LXR transcription factors as potential therapeutic targets to enhance the suppressive effects of radiation therapy on tumor growth through induction of macrophage cell death and activation of the inflammatory cascade.en_US
dc.languageengen_US
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physicsen_US
dc.sourceInternational Journal of Radiation Oncology Biology Physics [ISSN 0360-3016], v. 104 (4), p. 913-923en_US
dc.subject320111 Radiologíaen_US
dc.subject.otherTumor-Associated Macrophages
dc.subject.otherLiver-X-Receptors
dc.subject.otherAntitumor-Activity
dc.subject.otherLipid-Metabolism
dc.subject.otherCancer
dc.subject.otherActivation
dc.subject.otherMechanisms
dc.subject.otherPolarization
dc.subject.otherBiology
dc.subject.otherP53
dc.titleLXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiationen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ijrobp.2019.03.028
dc.identifier.scopus85064570676-
dc.identifier.isi000471624800035
dc.contributor.authorscopusid6506833060-
dc.contributor.authorscopusid7004374085-
dc.contributor.authorscopusid57206729085-
dc.contributor.authorscopusid55926663500-
dc.contributor.authorscopusid6602478628-
dc.contributor.authorscopusid6506777525-
dc.contributor.authorscopusid35514045400-
dc.contributor.authorscopusid55445301000-
dc.description.lastpage923-
dc.identifier.issue4-
dc.description.firstpage913-
dc.relation.volume104-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid30938142
dc.contributor.daisngid591076
dc.contributor.daisngid4588303
dc.contributor.daisngid6668944
dc.contributor.daisngid2864371
dc.contributor.daisngid30259663
dc.contributor.daisngid33173899
dc.contributor.daisngid225640
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Tabraue, C
dc.contributor.wosstandardWOS:Lara, PC
dc.contributor.wosstandardWOS:De Mirecki-Garrido, M
dc.contributor.wosstandardWOS:De la Rosa, JV
dc.contributor.wosstandardWOS:Lopez-Blanco, F
dc.contributor.wosstandardWOS:Fernandez-Perez, L
dc.contributor.wosstandardWOS:Bosca, L
dc.contributor.wosstandardWOS:Castrillo, A
dc.date.coverdateJulio 2019
dc.identifier.ulpgces
dc.description.sjr2,096
dc.description.jcr5,859
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Morfología-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-9920-8116-
crisitem.author.orcid0000-0003-0488-6307-
crisitem.author.orcid0000-0003-1443-7548-
crisitem.author.orcid0000-0003-1167-9787-
crisitem.author.orcid0000-0001-7802-465X-
crisitem.author.orcid0000-0002-2057-2159-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameTabraue Tarbay, Carlos-
crisitem.author.fullNameDe Mirecki Garrido, Mercedes-
crisitem.author.fullNameDe La Rosa Medina, Juan Vladimir-
crisitem.author.fullNameLópez Blanco, Félix-
crisitem.author.fullNameFernández Pérez, Leandro Francisco-
crisitem.author.fullNameCastrillo Viguera, Antonio Jesús-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

23
actualizado el 24-nov-2024

Citas de WEB OF SCIENCETM
Citations

21
actualizado el 24-nov-2024

Visitas

148
actualizado el 23-nov-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.